Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 11.01 Billion | USD 14.03 Billion | 2.8% | 2021 |
FrequentlyAsked Questions
Massive growth of general anxiety disorder treatment industry over next few years can be attributed to rise in work stress & hectic lifestyle.
According to Zion market research report, The global General Anxiety Disorder Treatment Market accrued earnings worth approximately 11.01 (USD Billion) in 2021 and is predicted to gain revenue of about 14.03 (USD Billion) by 2028, is set to record a CAGR of nearly 2.8% over the period from 2022 to 2028.
North America will contribute sizably towards the global market revenue over the projected timeline. A massive increase in General Anxiety Disorder Treatment Market size in sub-continent in 2022-2028 can be due to factors such as rise in cases of general anxiety among the workforce in countries such as the U.S. due to long working hours and hectic & irregular lifestyle.
The key industry participants leveraging business space include Pfizer, Inc., Merck & Co. Inc., AstraZeneca, GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, Johnson & Johnson, and H. Lundbeck A/S.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed